Join Toby Batten, Statistics Manager at Veramed and our special guest co-host, Carlo Lanza, as they discuss the evolution, challenges and road ahead of Clinical Oncology - focusing on Phase I, II and III specifically. Carlo and Toby will share how to think outside the box from a clinical and statistical point of view, address common pitfalls, improve study design, and more.
Our special guest, Carlo Lanza, brings over 20 years of industry experience as a Clinical Lead in the field of Oncology and Hematology phase 1 to 4, working for companies such as Novartis, Astrazeneca, and Pfizer and supporting also smaller biotechs through early phase clinical studies.
Register to improve your analysis, efficiency and discover a new way of thinking in a fast changing world of clinical Oncology.